India, US sign key pacts for cooperation in health, biomedical research

admin November 9, 2021
Updated 2021/11/09 at 1:47 PM

On Tuesday, Mansukh Mandaviya, India’s Union Minister for Health and Family Welfare, spoke at the 4th Indo-US Health Dialogue’s concluding session.

The two-day Dialogue served as a venue for the two nations to discuss a number of current health-related partnerships. During the two-day discussion, participants addressed topics such as epidemiological research and surveillance, vaccine development, One Health, zoonotic and vector-borne illnesses, health systems and policies, and so on.

At the end of the meeting, two memorandums of understanding were signed. The Ministry of Health and Family Welfare of the Republic of India and the Department of Health and Human Services of the United States of America have signed a Memorandum of Understanding (MOU) on health and biomedical research collaboration. Another Memorandum of Understanding (MoU) was signed between the Indian Council of Medical Research (ICMR) and the National Institute of Allergy and Infectious Diseases (NIAID) to collaborate on the International Centre for Excellence in Research (ICER).

“We all know that India and the United States are global partners, and we must work together to repair the global health infrastructure, whose flaws have become abundantly apparent during the current pandemic,” she added, “the minister of health said

Managing health emergencies, supporting digital health and innovation, mental health interventions, research and production related to diagnostics, therapeutics, and vaccines are all important areas where India and the United States can collaborate, especially given India’s low-cost research network and large production capacities. This has consequences not just for the US-India relationship, but for the whole globe, he added.

Indian generic medicines, according to Mandavia, have aided in lowering the cost of treating different illnesses across the world. “India is the primary source of high-quality generic pharmaceuticals for the poor globe. We’re also the world’s biggest producer of anti-tuberculosis medications. We can provide low-cost, high-quality medicine to people all around the globe by using this capacity “He expressed himself.

I also observe with pleasure the increasing convergence between the regulators of both nations and anticipate more concrete results as well as a collaborative effort on this subject at global fora, he added.


Source: Mint

Share this Article
Leave a comment

Leave a Reply

Your email address will not be published.